[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@JacobPlieth
"Radiance Biopharma has links to $SGEN and last year licensed Biocytogen's anti-HER2 x TROP2 bispecific ADC YH012/RB-201. Now it's the latest to get into ROR1 $IPN.PA $STRO $ZLAB $ZNTL $IMNM" @JacobPlieth on X 2025-02-19 09:50:39 UTC 29.9K followers, 3510 engagements
"Here we go: $PFE just went into ph3 with Kat6 $OLMA" @JacobPlieth on X 2025-07-16 11:27:35 UTC 29.9K followers, 3284 engagements
"Nerd alert What do the latest proposed INNs tell us about $MGNX $AZN $BNTX $GSK $IVBXF and other ADCs Via @ApexOnco - H/t @raffcolo" @JacobPlieth on X 2025-07-21 08:38:24 UTC 29.9K followers, 3447 engagements
"PD-1 x VEGF is all very well but how about PD-1 x Lag-3 3SBio reckons it's worth taking into the clinic $PFE $BMY" @JacobPlieth on X 2025-06-16 08:15:44 UTC 29.9K followers, 5822 engagements
"@spontonic Wasn't that the entire reason why "parties connected to" $SMMT leaked the alleged deal talks to Berg Standard bio playbook" @JacobPlieth on X 2025-07-16 17:28:32 UTC 29.9K followers, 1257 engagements
"@AppleHelix Given what $MRK stands to pay under the PD-1 x VEGF deal even considering the payaway did she/Lanova sell out too cheaply to Sino" @JacobPlieth on X 2025-07-18 13:36:03 UTC 29.9K followers, XXX engagements
"Admirable effort by FDA's Deepti Telajara to present the current treatment paradigm for multiple myeloma $JNJ $BMY $GSK" @JacobPlieth on X 2025-07-17 12:18:51 UTC 29.9K followers, 9316 engagements
"$COGT +25% as bezuclastinib safety remains in the spotlight. Via @ApexOnco - $BPMC $SNY" @JacobPlieth on X 2025-07-07 18:07:11 UTC 29.9K followers, 6627 engagements
"#Varda $187m raise to manufacture "drugs in space" got lots of traction yesterday so I guess people think use of microgravity is pretty novel. But apparently $LLY was doing this already in. 2016 h/t @raffcolo" @JacobPlieth on X 2025-07-11 11:43:00 UTC 29.9K followers, 2865 engagements
"KAT6 which recently saw the entry of $IDYA could soon see $OLMA start ph1 and $PFE enter ph3. But how combinable are these molecules given the tox Via @ApexOnco -" @JacobPlieth on X 2025-01-06 15:06:43 UTC 29.9K followers, 6760 engagements
"What in the wide wide world of sports $SONN" @JacobPlieth on X 2025-07-14 10:40:47 UTC 29.9K followers, 8822 engagements
"@MaverickNY @chuminhua432 @jbdotdotdot Also the clue is in the ct-gov exclusion criteria" @JacobPlieth on X 2025-07-04 09:23:36 UTC 29.9K followers, 3091 engagements
"Fascinating Evercore ISI webinar going on right now about disconnect between value of Sino deal and what $MRK owes Lanova on the PD-1 x VEGF. In summary: XX% of $588m MRK up front and XX% of the $300m tech transfer actually went to Genscript () $LEGN" @JacobPlieth on X 2025-07-18 13:23:35 UTC 29.9K followers, 11K engagements
"Quite the tangled web: Dualitybio's Her2 ADC trastuzumab pamirtecan is licensed to $BNTX (of $BMY PD-L1 x VEGF fame) ex-China and to 3SBio (of $PFE PD-1 x VEGF fame) in China" @JacobPlieth on X 2025-06-06 08:53:59 UTC 29.9K followers, 4862 engagements
"Is anyone able to translate this into English TIA $SONN" @JacobPlieth on X 2025-07-14 13:36:13 UTC 29.9K followers, 4921 engagements
"So judging by panellists' comments the key issue was $GSK's refusal to investigate lower Blenrep doses. Pertinent slide from FDA:" @JacobPlieth on X 2025-07-17 16:51:27 UTC 29.9K followers, 3938 engagements
"$JNJ first announced TAR-200 filing on XX Jan but never announced the acceptance. Today's PR likely result of mention of priority review dribbled out at GS conf in June & on yesterday's earnings call. Still no idea when filing was actually accepted" @JacobPlieth on X 2025-07-17 13:07:49 UTC 29.9K followers, 2415 engagements
"Support for $PFE mevrometostat's ph3 plan but comparison vs $IPN.PA Tazverik Cello-1 readout doesn't add up. Via @ApexOnco at #GU25 - $ORIC" @JacobPlieth on X 2025-02-13 15:04:55 UTC 29.9K followers, 12.9K engagements
"I scoured the FDA's cache of CRLs and found six that relate to novel oncology drugs. Includes first formal disclosure that Akeso's penpulimab got a CRL in 2024. Via @ApexOnco - $AVEO $IMMU $GILD $CHRS $ALPMF $CKPT" @JacobPlieth on X 2025-07-11 12:30:59 UTC 29.9K followers, 5760 engagements
"Guess who's about to take a SC anti-PD-1 into phase X Via @ApexOnco - $ONC $BGNE $RHHBY $AZN $MRK $BMY $PFE" @JacobPlieth on X 2025-07-04 10:11:15 UTC 29.9K followers, 4209 engagements
".and already my head hurts (slide from $GSK)" @JacobPlieth on X 2025-07-17 12:57:38 UTC 29.9K followers, 1907 engagements
"$GSK Blenrep should return to the US #ASCO24 hears. Via @ApexOnco - $JNJ $BMY $PFE $TSVT $LEGN $REGN" @JacobPlieth on X 2024-06-02 12:37:07 UTC 29.9K followers, 14K engagements
"Another bombshell via Evercore: founder of Lanova is married to the founder of $IMAB (did I hear that right)" @JacobPlieth on X 2025-07-18 13:34:34 UTC 29.9K followers, 3112 engagements
".and more this time from the FDA's Andrea Baines $BMY $JNJ $GSK $LEGN" @JacobPlieth on X 2025-07-17 13:22:57 UTC 29.9K followers, 2714 engagements
"I'm not sure what this says about EQRX's business model now. Somewhat disappointing to see it having to resort to the Spac route $CMLTU" @JacobPlieth on X 2021-08-06 12:25:48 UTC 29.9K followers, XX engagements